胆汁淤积性肝病Cholestatic Liver Disease

Cholestatic Liver Disease


2008 Humana Press
999 Riverview Drive, Suite 208
Totowa, New Jersey 07512

All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted
in any form or by any means, electronic, mechanical, photocopying, microfilming, recording,
or otherwise without written permission from the Publisher.
The content and opinions expressed in this book are the sole work of the authors and editors, who
have warranted due diligence in the creation and issuance of their work. The publisher, editors,
and authors are not responsible for errors or omissions or for any consequences arising from the
information or opinions presented in this book and make no warranty, express or implied, with
respect to its contents.
Due diligence bas been taken by the publisbers, editors, and authors of this book to assure the accuracy
of the information published and to describe generally accepted practices. The contributors
herein have carefully checked to ensure that the drug selections and dosages set forth in this text
are accurate and in accord with the standards accepted at the time of publication. Notwithstanding,
since new research, changes in government regulations, and knowledge from clinical experience relating
to drug therapy and drug reactions constantly occur, the reader is advised to check the product
information provided by the manufacturer of each drug for any change in dosages or for additional
warnings and contraindications. This is of utmost importance when the recommended drug herein is
a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages
and treatment strategies for individual patients. Further, it is the responsibility of the health care
provider to ascertain the Food and Drug Administration status of each drug or device used in their
clinical practice. The publisbers, editors, and authors are not responsible for errors or omissions or
for any consequences from the application of the information presented in this book and make no
warranty, express or implied, with respect to the contents in this publication.
This publication is printed on acid-free paper. ®
ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed
Library Materials.
Cover illustration: Figure 1, Chapter 4, "Primary Sclerosing Cholangitis," by Kelly Warren Burak,
and Figures 1-3, Chapter 5, "Overlap Syndrome with Autoimmune Hepatitis," by Alastair Smith.
Cover design by Karen Schulz
Production Editor: Michele Seugling
For additional copies, pricing for bulk purchases, andlor information about other
Humana titles, contact Humana at the above address or at any of the following numbers:
Tel: 973-256-1699; Fax: 973-256-8341; or visit our website at
Photocopy Authorization Policy:
Authorization to photocopy items for internal or personal use, or the internal or personal use of
specific clients, is granted by Humana Press, provided that the base fee of US $30.00 per copy is
paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923. For
those organizations that have been granted a photocopy license from the CCC, a separate system
of payment bas been arranged and is acceptable to Humana Press. T

游客，如果您要查看本帖隐藏内容请回复